Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RILONACEPT vs RIPRETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RILONACEPT vs RIPRETINIB: Safety Overview

Metric RILONACEPT RIPRETINIB
Total FAERS Reports 843 4,432
Deaths Reported 14 465
Death Rate 1.7% 10.5%
Hospitalizations 65 948
Average Patient Age 51.9 yrs 66.8 yrs
% Female Patients 68.2% 45.3%
FDA Approval Date N/A May 15, 2020
Manufacturer Kiniksa Pharmaceuticals (UK), Ltd. Deciphera Pharmaceuticals, LLC
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription